- 期刊
The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
延伸閱讀
- Cheng, Y. W., Malik, U., & Chen, Y. C. (2016). The Risk Factors of Renal Function Deterioration in Type 2 Diabetic Patients: The Experience of a Taiwan Local Hospital. 南臺灣醫學雜誌, 12(1), 19-28. https://doi.org/10.6726/MJST.201607_12(1).0003
- Chiu, C. P., & Liang, Y. P. (2008). The Effect of Rosiglitazone on Poorly Controlled Diabetes in Patients Taking Three Oral Antidiabetic Agents. Mid-Taiwan Journal of Medicine, 13(2), 75-81. https://doi.org/10.6558/MTJM.2008.13(2).2
- Liu, Y., Cheng, B. C., Chang, W. X., Yang, C. H., Moi, S. H., & Chen, J. B. (2016). Risk Factors for Residual Renal Function Decline in Incident Peritoneal Dialysis without Diabetes. Acta Nephrologica, 30(3), 127-134. https://doi.org/10.6221/AN.2016003
- 陳銘鴻、康玉嬋、王佩文（2009）。Possible Mechanism of Contraindication to Acarbose in Type 2 Diabetic Patients with Renal Failure。內科學誌，20(5)，434-439。https://doi.org/10.6314/JIMT.2009.20(5).07
- Assal, H. S., Tawfeek, S., Rasheed, E. A., Lebedy, D. E., & Thabet, E. H. (2013). Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus. Clinical Medicine Insights: Endocrinology and Diabetes, (2013), 7-13. https://doi.org/10.4137/CMED.S12633